Cargando…
Basic & applied pharmacokinetics self assessment /
To exercise the best possible judgment in patient care, medication plans should be selected for the maximum efficacy and safety for each individual patient. Be confident in your approach with ASHP's Basic & Applied Pharmacokinetics Self Assessment, a new resource from John E. Murphy, author...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Bethesda, MD :
American Society of Health-System Pharmacists,
2014.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn890717709 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr un||||||||| | ||
| 008 | 140917s2014 mdu o 000 0 eng d | ||
| 040 | |a STJ |b eng |e rda |e pn |c STJ |d STJ |d N$T |d OCLCF |d OCL |d VLB |d OCLCQ |d OCLCO |d OCLCQ |d D6H |d ICA |d OCLCO |d OCLCA |d TSC |d OCLCO |d AGLDB |d OCLCO |d STJ |d VNS |d OCLCO |d OCLCQ |d VTS |d S9I |d STF |d M8D |d AJS |d TUHNV |d OCLCQ |d OCLCO |d OCL |d EBLCP |d OCLCQ |d OCLCO |d U3W |d OCLCL | ||
| 020 | |a 9781585284405 |q (electronic bk.) | ||
| 020 | |a 1585284408 |q (electronic bk.) | ||
| 020 | |z 1585284386 | ||
| 020 | |z 9781585284382 | ||
| 029 | 1 | |a DEBBG |b BV042795094 | |
| 029 | 1 | |a DEBSZ |b 481285326 | |
| 029 | 1 | |a AU@ |b 000056931989 | |
| 035 | |a (OCoLC)890717709 | ||
| 050 | 4 | |a RM301.5 |b M87 2014eb | |
| 060 | 4 | |a QV 18.2 |b M877 2014eb | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.7 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Murphy, John E., |d 1945- |e author. |1 https://id.oclc.org/worldcat/entity/E39PCjwpx9Hp6CJ76VGx7Btmbb | |
| 245 | 1 | 0 | |a Basic & applied pharmacokinetics self assessment / |c John E. Murphy. |
| 246 | 3 | |a Basic and applied pharmacokinetics self assessment | |
| 264 | 1 | |a Bethesda, MD : |b American Society of Health-System Pharmacists, |c 2014. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 588 | 0 | |a Print version record. | |
| 520 | |a To exercise the best possible judgment in patient care, medication plans should be selected for the maximum efficacy and safety for each individual patient. Be confident in your approach with ASHP's Basic & Applied Pharmacokinetics Self Assessment, a new resource from John E. Murphy, author of ASHP's Clinical Pharmacokinetics, Fifth Edition, which offers questions and exercises with answers and detailed solutions t. | ||
| 505 | 8 | |a Table 1.7-2. Clearance (CL) -- Table 1.7-3. Digoxin Bioavailability (F) of Dosage Forms -- Dosing Strategies -- Estimating Digoxin Clearance (for Adults and Children andgt -- 12 Years of Age) -- Estimating Digoxin Dose for a Desired Cssavg (for Adults) -- Estimating V in Patients with Reduced Renal Function -- References -- Self-Assessment Problems -- Answers -- 1.8. Unfractionated Heparin and Low Molecular Weight Heparins -- Heparin Dosing and Monitoring Strategies for Confirmed Venous Thromboembolism -- Pharmacokinetic/Pharmacodynamic Dosing Approach for UFH Using Activated Clotting Time (ACT) -- Table 1.8-1. aPTT and Weight-Based Dosing Adjustment Scheme for UFH -- Table 1.8-2. Protamine Doses for Reversal of LMWH -- References -- Self-Assessment Problems -- Answers -- 1.9. Lithium -- Table 1.9-1. Lithium Dosage Forms -- Table 1.9-2. Select Drug-Drug Interactions -- Dosing Strategies -- Dosage and Clearance Prediction Using Demographics -- References -- Self-Assessment Problems -- Table 1.9-3. Recommended Dosages Required to Achieve a Serum Level of 0.6 to 1.2 mEq/L -- Answers -- 1.10. Phenobarbital -- Pharmacokinetic Parameters -- Table 1.10-1. Volume of Distribution by Age Group -- Table 1.10-2. Clearance by Age Group -- Self-Assessment Problems -- Answers -- 1.11. Phenytoin/Fosphenytoin -- Pharmacokinetic Parameters -- Table 1.11-1. Volume of Distribution -- Table 1.11-2. Reported Values of Vmax and Km -- Key Equations -- Self-Assessment Problems -- Answers -- 1.12. Valproic Acid -- Pharmacokinetic Parameters -- Table 1.12-1. Clearance by Age in the Absence of Clearance-Altering Factors -- Table 1.12-2. Bioavailability of Dosage Forms -- References -- Self-Assessment Problems -- Answers -- 1.13. Vancomycin -- Pharmacokinetic Parameters -- Table 1.13-1. Volume of Distribution by Age Group -- Table 1.13-2. Average Clearance Values. | |
| 505 | 8 | |a Dosing Strategies -- Infants -- Adults -- AUC -- References -- Self-Assessment Problems -- Answers -- 1.14. Warfarin -- Pharmacokinetic Parameters -- Table 1.14-1. Elimination Half-Lives of Vitamin K-Dependent Proteins -- Drug-Drug Interactions -- Table 1.14-2. Select Clinically Significant Warfarin Drug Interactions -- Dosing Strategies -- Table 1.14-3. Flexible Initiation Nomogram for Warfarin -- Table 1.14-4. Warfarin Dosing Adjustment Guidelines for INR Goal of 2-3 -- Self-Assessment Problems -- Answers -- SECTION II: SOLUTIONS -- 2.1. General Pharmacokinetic Applications -- Solutions -- 2.2. Medication Dosing in Overweight and Obese Patients -- Solutions -- 2.3. Estimating Creatinine Clearance -- Solutions -- 2.4. Renal Drug Dosing -- Solutions -- 2.5. Aminoglycoside Antibiotics -- Solutions -- Estimating k by Estimating Aminoglycoside Clearance (CLag) from Creatinine Clearance -- Estimating the Peak and Trough Concentrations Using the Population Estimates -- Estimating k from Estimated Aminoglycoside Clearance (CLag) -- Estimating the Peak Concentration -- 2.6. Carbamazepine -- Solutions -- 2.7. Digoxin -- Solutions -- 2.8. Unfractionated Heparin and Low Molecular Weight Heparins -- Solutions -- 2.9. Lithium -- Solutions -- 2.10. Phenobarbital -- Solutions -- 2.11. Phenytoin/Fosphenytoin -- Solutions -- 2.12. Valproic Acid -- Solutions -- 2.13. Vancomycin -- Solutions -- 2.14. Warfarin -- Solutions. | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Pharmacokinetics |v Examinations, questions, etc. | |
| 650 | 0 | |a Pharmacokinetics. | |
| 650 | 1 | 2 | |a Pharmacokinetics |
| 650 | 6 | |a Pharmacocinétique |v Examens, questions, etc. | |
| 650 | 6 | |a Pharmacocinétique. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Pharmacokinetics |2 fast | |
| 655 | 2 | |a Programmed Instruction | |
| 655 | 7 | |a programmed textbooks. |2 aat | |
| 655 | 7 | |a Programmed instructional materials |2 fast | |
| 655 | 7 | |a Examinations |2 fast | |
| 655 | 7 | |a Examinations. |2 lcgft | |
| 655 | 7 | |a Programmed instructional materials. |2 lcgft | |
| 655 | 7 | |a Matériel d'enseignement programmé. |2 rvmgf | |
| 710 | 2 | |a American Society of Health-System Pharmacists, |e issuing body. | |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=30183695 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL30183695 | ||
| 938 | |a EBSCOhost |b EBSC |n 887133 | ||
| 994 | |a 92 |b IZTAP | ||